Case control study of neonatal intensive care / special care nursery (NICU/SCN) admissions and antipsychotic exposure using data from the National Register of Antipsychotic Use in Pregnancy (NRAMP)

The National Register of Antipsychotic Medications in Pregnancy (NRAMP) is an ongoing study with data collected from 300+ women across Australia who have used antipsychotics during pregnancy. Extensive information on maternal & infant health/well-being pregnancy, birth outcomes, and the first 12 months has been collected, to explore possible effects of antipsychotic agents on fetal / infant health and development. The aim of this study is to determine whether newborns admitted to neonatal intensive care / special care nursery (NICU/SCN) have been exposed to higher doses of antipsychotics in utero than those who were not admitted to NICU/SCN.